About us

Our Vision

Making patients’ lives safer and more livable

Our Mission

We redefine drug delivery by replacing injections with oral formulations to increase patient compliance and provide safe medication around the world

status quo

NovoArc GmbH was founded in October 2021 and we are currently expanding our product portfolio

The NovoArc Team

We are a team of highly motivated scientists with entrepreneurial spirit.

Teamspirit is essential for NovoArc. Each and everyone of the team members has their own assets which are vital for our success. 

If you want to become part of the Team check out or job offers and contact us!

Job offer: Lab Technician

Job offer: Quality Manager

Dr. David
Wurm

CEO

David is a process engineer and has a PhD in the field of biotechnology. For several years he has been doing project management and is responsible for communication with partners and customers, for the coordination of the team and for financials. Because of his trainings in the field of business development, management and law David is CEO and co-founder of NovoArc GmbH.


Dr. Julian
Quehenberger

CTO

In his PhD Thesis Julian investigated biotechnological applications of extremophilic microorganisms. In the last few years he developed the underlying technology necessary to replace injection with pills. Globally he is probably the only person who can produce the necessary lipids in the required quality and quantity. Because of his great knowledge in this field and his spirit of innovation Julian is CTO, managing director and co-founder of NovoArc GmbH.

Prof. Oliver
Spadiut

scientific advisor

Oliver is Professor in Biotechnology well known in this field. His expertise in industrial R&D, his scientific competence (>150 publications) and his wide international network in the biotech industry (80% industry-oriented projects in cooperation with major pharmaceutical companies) are extremely valuable to the company. Oliver is scientific advisor and co-founder of NovoArc GmbH.


Christina
Horn, MSc.

Scientist
Liposome Formulation

Christina studied Biochemistry and Molecular Biomedicine and focused on liposome formulation during her Master Thesis at Medical University Graz. With the gained knowledge she is a great asset to the NovoArc Team. Her main focus is the formulation of Archaeosomes with different active pharmaceutical ingredients.

Matthias
Pichler, BSc.

Scientist
Lipid Purification

Matthias studied Biotechnology and Bioengineering at TU Wien. During his studies he already joined the working group of the founder team more than two years ago and has gathered a lot of expertise in the field of lipid purification. Matthias is a creative mind and loves implementing innovative technologies.

Philipp
Crepaz, BSc.

Scientist
Lipid Production

Philipp studied Technical Chemistry at TU Wien and focused on lipid production during his Master Thesis. Philipp is a very accurate and precise person who is responsible for the lipid production as well as analytics.



Patricia
Barth, BSc.

Lab Technician
Lipid Extraction and Purification

Patricia brings in a lot of experience due to her previous work in industrial laboratories and her studies in Food Science and Biotechnology at the BOKU University in Vienna. She is responsible for the day-to-day work in the field of lipid extraction and purification.

Marlene
Grabner, BSc.

Junior Scientist
Support Labwork

Marlene is currently studying Technical Chemistry. As a part time employee, she helps out in the lab and supports the team in the field of lipid production and purification as well as programming and in-silico analysis of the lipids.

Introducing our Advisors

All this would not be possible without the support from experts in the field. We highly appreciate the help from our advisory board.

Klara Brandstätter, MSc

CEO at
I.E.C.T. Hermann Hauser

Dr. Sylvia Nanz

Medical Director
Pfizer

Prof. Markus Zeitlinger

Head Clinical Pharmacology
Medical University of Vienna

Dr. Andreas Wagner

Head Liposome Technology
Polymun Scientific

Supported by